Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
30.00
+0.18 (0.60%)
Jun 15, 2026, 4:00 PM EDT - Market closed
Stoke Therapeutics Employees
Stoke Therapeutics had 170 employees as of December 31, 2025. The number of employees increased by 42 or 32.81% compared to the previous year.
Employees
170
Change (1Y)
42
Growth (1Y)
32.81%
Revenue / Employee
$188,706
Profits / Employee
-$998,629
Market Cap
1.87B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 170 | 42 | 32.81% |
| Dec 31, 2024 | 128 | 18 | 16.36% |
| Dec 31, 2023 | 110 | -7 | -5.98% |
| Dec 31, 2022 | 117 | 15 | 14.71% |
| Dec 31, 2021 | 102 | 23 | 29.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Iovance Biotherapeutics | 975 |
| ADMA Biologics | 647 |
| Lakefront Biotherapeutics NV | 558 |
| Vericel | 398 |
| Ocular Therapeutix | 325 |
| Viridian Therapeutics | 252 |
| Nanobiotix | 100 |
STOK News
- 7 days ago - Stoke Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 11 days ago - Stoke Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 12 days ago - Stoke Therapeutics Transcript: AGM 2026 - Transcripts
- 18 days ago - Stoke Therapeutics to Present at Upcoming Investor Conferences in June - Business Wire
- 4 weeks ago - Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
- 5 weeks ago - Stoke Therapeutics reports Q1 EPS (79c), consensus (84c) - TheFly
- 5 weeks ago - Stoke Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 5 weeks ago - Stoke Therapeutics Earnings release: Q1 2026 - Filings